Weight Loss Injections for Type 2: What They Are and How They Work

How do these injections affect blood sugar as well as weight?

GLP-1 medicines were originally developed for type 2 diabetes before their weight-loss potential became clear, and that history matters. They work partly by stimulating insulin release in response to meals and partly by slowing how quickly food leaves the stomach. The result is a double effect: blood sugar rises more gradually after eating, and hunger signals to the brain are blunted. You tend to feel full sooner and stay full longer.

Tirzepatide goes a step further by also activating GIP receptors, a second gut-hormone pathway involved in both energy storage and appetite. For people with type 2 diabetes, this dual action can improve glycaemic control alongside weight loss. That is useful, but it also means your blood sugar levels may shift meaningfully during the first weeks of treatment. Anyone already taking insulin or sulfonylureas needs to discuss this with their prescriber before starting, because hypoglycaemia becomes a real consideration. The specific interactions between these injections and type 2 diabetes treatment are worth understanding in detail.

A practical habit worth building: check your blood glucose at a consistent time each morning during the first month. It takes under a minute and gives you something concrete to share with your prescriber at review.

Who with type 2 diabetes is actually eligible for a weight loss injection?

For private treatment, the licensed eligibility criteria come from each medicine's Summary of Product Characteristics. Adults with a BMI of 30 or above qualify. So do adults with a BMI between 27 and 29.9 who have at least one weight-related condition, and type 2 diabetes sits squarely in that category. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. BMI alone never guarantees approval; a prescriber looks at the whole picture, including your current diabetes management.

On the NHS, the picture is more complicated. NICE's appraisal of tirzepatide sets stricter thresholds for NHS access, tied to BMI and the number of weight-related conditions present. The rollout is phased, meaning not everyone who is clinically eligible can access it through their GP practice yet. You can read through how NHS access compares to the private route to understand where you might stand. For people who want to start now without waiting, a regulated private service is the practical alternative, subject to that clinical assessment.

Under-18s are not eligible. Pregnancy, breastfeeding and trying to conceive are all situations where these medicines are not recommended.

What results do people with type 2 see, and are there risks specific to their situation?

In the SURMOUNT-1 trial (a 72-week study involving thousands of adults) tirzepatide produced average weight reductions of around 20 to 21 percent at the highest dose. The STEP 1 trial, published in the New England Journal of Medicine, showed semaglutide 2.4mg producing around 15 percent average loss over 68 weeks. These figures came from trials that included adults with type 2 diabetes in some analyses; the specific diabetes-population results are worth discussing with a prescriber who knows your HbA1c and current regimen.

Side effects are predominantly gastrointestinal: nausea, loose stools, constipation and indigestion are the most reported, usually peaking in the first weeks after starting or after a dose increase. Serious but rarer concerns include acute pancreatitis, severe, persistent stomach pain that may radiate to the back is the warning sign, and urgent medical attention is the right response. The MHRA issued a Drug Safety Update on this in January 2026, reinforcing that it applies across GLP-1 medicines. You can report any suspected side effect to the MHRA's Yellow Card scheme.

For a broader picture of the options available, if you are weighing up which medicine might suit your situation, understanding what types of weight loss injections are available sets out the differences clearly.

How does getting a prescription through a regulated online pharmacy work?

The process at nume follows a fixed clinical sequence. You complete a free consultation, questions about your health, medications, weight history and diabetes management. A GPhC-registered Independent Prescriber reads it the same day. Not software. A real clinician, who can approve, decline or ask follow-up questions. If approved as clinically suitable and you order by midday on a working day, your treatment is dispatched the same day and delivered free the next working day by DPD in plain, unbranded packaging.

One transparent price covers the consultation, prescription, medicine and delivery. There are no subscriptions and no auto-renewals; every repeat order goes through the same clinical review. If you want to understand what that pricing looks like relative to the market, this breakdown of what weight loss injections cost in the UK covers it honestly. You can also read about how nume is set up as a clinician-led service if you want to check the detail before starting.

Questions about your specific situation? Our team is available seven days a week via the contact page. When you're ready, check your eligibility and start your free consultation.